An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia

This publication has 20 references indexed in Scilit:

• Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy.
  Journal of Clinical Oncology, 1998
• Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia
  British Journal of Cancer, 1998
• A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curve
  Cancer Chemotherapy and Pharmacology, 1996
• Transfusion requirements, risks, and costs for patients with malignancy
  Transfusion, 1995
• The Frequency of Red Cell Transfusion for Anemia in Patients Receiving Chemotherapy A Retrospective Cohort Study
  American Journal of Clinical Oncology, 1993
• Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated Anemia
  JNCI Journal of the National Cancer Institute, 1992
• Time- and dose-dependent inhibition of erythrocyte glutathione peroxidase by cisplatin
  Biochemical Pharmacology, 1988
• Correlation between free platinum AUC and total platinum measurement 24 h after i.v. bolus injection of cisplatin in humans
  Cancer Chemotherapy and Pharmacology, 1988
• Cisplatinum: A review, with special reference to cellular and molecular interactions
  Inflammation Research, 1984
• Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites
  Journal of Clinical Investigation, 1980